User interface for a flow cytometer system

Information

  • Patent Grant
  • 8229707
  • Patent Number
    8,229,707
  • Date Filed
    Monday, July 4, 2011
    12 years ago
  • Date Issued
    Tuesday, July 24, 2012
    11 years ago
Abstract
A method of extracting and analyzing a data set from a flow cytometer system of the preferred embodiment comprises the steps of (1) running a sample and saving all collected raw data, (2) viewing raw (or “unmodified”) data, (3) modifying the raw data (e.g., scaling and/or culling the raw data), (4) reviewing and saving the modified data, and (5) exporting the saved data. Once the sample has been run and all collected data have been saved, the user can repeat the steps of modifying the raw data, saving the modified data, and exporting the saved data as many times as necessary and/or desirable.
Description
TECHNICAL FIELD

The present invention relates generally to the field of flow cytometers, and more particularly to user interfaces in the field of flow cytometers.


BACKGROUND

A typical flow cytometer detector has a limited collection range. In quantitative terms, the collection range for a typical flow cytometer with a photomultiplier tube is approximately four decades, whereas the signal range of the objects may span more than five decades across experiments. In simple terms, the collection range of a typical flow cytometer is smaller than the signal range of the objects. For this reason, the typical detector is supplied with a gain level for the photomultiplier tubes and/or an amplifier. Detectors typically collect data relative to an object's size (light scatter) or brightness (fluorescence); both types of data are often collected on each object detected. To collect signals from small or faint objects, the gain level is increased. With an increased gain level, however, the signals from large or bright objects are too intense to be collected. To collect signals from large or bright objects, the gain level is decreased. With a decreased gain level, however, the signals from small or faint objects are too weak to be collected.


As shown in FIG. 1, the typical flow cytometer user interface involves the preparation and running of a pilot sample in order to appropriately set the gain control and define the user-set collection range. This involves the steps of (1) setting the gain control to what the user predicts will provide the desired collection range, (2) running a pilot sample through the flow cytometer, (3) viewing the pilot data/signal collected from the pilot sample, (4) identifying the extent to which, if any, the gain setting should be modified to achieve a more suitable collection range, and (5) repeating steps 1-4 as needed until the desired collection range is achieved. Since the typical detector is unable to obtain useable data from signals beyond its collection range, and since the typical detector requires a pre-set gain level, the typical user interface does not allow the user to adjust the signal gain level/scaling (e.g. photomultiplier tube voltages) after data acquisition is complete. Observing data signals outside of the pre-set collection range is only possible if (1) the user changes the detector gain levels and (2) the user is able to run an additional test sample that is relatively homogenous to the previous samples and is temporally stable.


The limitations of the user interface of typical flow cytometer systems have at least four disadvantages: (1) the expenditure of valuable user time spent on the gain-setting process to ensure it is set correctly; (2) the requirement of significantly more sample to determine the proper gain settings (i.e. more sample is used setting the gain than is actually used in the data collection run), (3) the potential loss of valuable data because the user incorrectly anticipated the actual signal range and a portion or more of the input signals are outside the user-set “active” dynamic collection range and are not collected; and (4) the inability to observe and “undo” changes in user-set gain/scaling settings without running additional samples.


As flow cytometer systems incorporate features that significantly increase the collection ranges to a range that approaches the object signal ranges (e.g. broad dynamic range flow cytometers), there will be a need in the flow cytometer field to create a new and improved flow cytometer user interface that avoids or minimizes one or more of these disadvantages. This invention provides such new and improved flow cytometer user interface.





BRIEF DESCRIPTION OF THE FIGURES


FIG. 1 is a schematic block diagram of a flow cytometer user interface of the prior art.


FIGS. 2 and 3A-3C are schematic block diagrams of a flow cytometer user interface in accordance with the preferred embodiment of the present invention.





DESCRIPTION OF THE PREFERRED EMBODIMENT

The following description of the preferred embodiment of the invention is not intended to limit the invention to this preferred embodiment, but rather to enable any person skilled in the art of flow cytometers to make and use this invention.


The preferred embodiment of the invention extracts data from the full dynamic range of a flow cytometer in a single run, and then manipulates scaling and/or culling factors across the full dynamic range after the data have been collected. The data of the full dynamic range are collected and stored in raw or unmodified form during the acquisition step and the user interface can display the unmodified data and/or modified data. Because scaling and/or culling factors can be applied after the acquisition step is complete, the user interface facilitates real-time comparisons between the raw and modified data on a single, unique sample run. Scaling and/or culling can be adjusted or undone without the need to re-run pilot samples, which saves time, reduces the amount of sample required, and eliminates the potential of lost data due to incorrect gain settings.


As shown in FIG. 2, the flow cytometer user interface of the preferred embodiment comprises the steps of (1) running the sample and saving all collected data, (2) viewing the raw (or “unmodified”) data, (3) modifying the raw data (e.g., scaling and/or culling the raw data), (4) reviewing and saving the modified settings, and (5) exporting the saved data. Once the sample has been run and all collected data have been saved, the user can repeat the steps of modifying the raw data, saving the modified settings, and exporting the saved data as many times as necessary or desirable without the need to run an additional sample.


The user interface of the preferred embodiment may be coupled to any suitable diagnostic and/or analysis system. In the preferred embodiment, the user interface is in electronic communication with an advanced flow cytometer that has a collection range that approaches the total detected object signal range (e.g. broad dynamic range flow cytometers). While the advanced flow cytometer may be any suitable flow cytometer system, it is preferably an advanced flow cytometer as described in U.S. Patent Publication Number 2006/0219873, entitled “Detection System for a Flow Cytometer” and filed on 31 Mar. 2006, which is incorporated in its entirety by this reference. In an alternative embodiment, the user interface is in electronic communication with a composite of several narrow dynamic range flow cytometers.


In the preferred embodiment, the first step of ‘running the sample and saving all collected data’ (102) includes the collection (i.e., acquisition) (103a) and electronic storage (103b) of the full dynamic range of input signals (in raw, unmodified format) from a flow cytometer sample. The full dynamic range of input signals is preferably defined as the range of input signals that provides a 1:100,000 ratio, and more preferably a 1:1,000,000 ratio, between the faintest objects and the brightest objects. The full dynamic range of input signals is preferably captured by a 24bit process, which translates to roughly 16,700,000 levels of information, but may alternatively be captured by any suitable process. Preferably, the captured data includes an error rate induced by electric noise of less than one-percent. In the preferred embodiment, the data are collected in a raw, unmodified format without the use of, or the adjustment in, the gain level of the detector. The collection of the data in this manner eliminates the expenditure of valuable user time and avoids the potential loss of valuable data through misconfiguration of the system.


The second step of ‘viewing the raw data’ (104) permits the user to observe the raw data (105a) that has been collected and stored from the sample run and identify the anticipated appropriate modifications (105b) for the sample. In the preferred embodiment, the user interface presents the raw data (105) after the acquisition is complete. In an alternative embodiment, the user interface presents the raw data (105) during the acquisition step. In a first “local” variation of the preferred embodiment, the original, raw data set to be viewed is acquired from a flow cytometer coupled to the user interface; in a second “remote” variation, the original data set is acquired from an electronic storage medium. When the user interface is coupled to a broad dynamic range flow cytometer, as in the preferred embodiment, the user interface can display data (105) from greater than four decades of signal.


The third step of ‘modifying the raw data’ (106) permits the user (107) to manipulate (e.g. scale and/or cull) the data collected across the full dynamic range of input signals (112) from the flow cytometer sample. In this step, the user interface permits the user to perform real-time comparisons between the raw and modified data (114) on a single, unique sample run. Additionally, scaling and/or culling can be adjusted or undone without the need to re-run pilot samples allowing multiple adjustments on the same initial data set.


In the preferred embodiment, the user scales and/or culls the raw data to select a subset of signals that corresponds to the desired sample population. The user is permitted to apply gain and scaling factors to the acquired data. This is performed independently of the acquisition step and permits the user to adjust the bounds of the data (116). In an alternative embodiment, the user interface automatically scales and/or culls the raw data based on an appropriate algorithm. In this alternative embodiment, the user interface may accept a user command that corresponds to, or identifies, the desired sample population. The modifying of raw data preferably occurs after data acquisition is complete, and multiple signal gain/scaling adjustments can be made on a single, unique data set.


The user interface of the preferred embodiment may be virtual, physical, or any suitable combination. In the virtual variation, the knobs, sliders, and other controls are shown only on a display and not in a physical unit. The controls, whether virtual or physical, permit the single, unique data set to be modified in a step-wise, sequential fashion. Alternatively, the user interface may permit the single, unique data to be repeatedly or iteratively modified. Scaling is preferably applied hierarchically based on forward scatter, which can be expanded to include any or all of the available data channels (scatter and fluorescent) in a progressive fashion. Scaling may, however, be applied in any suitable manner.


Any number of subsets of data can be generated that correspond to one or more sample populations (118) contained within the raw data set. Preferably, the user interface permits each subset (i.e. modification) of the raw data and the settings used to generate the desired subset of data to be individually saved, recorded, and identified. Alternatively, the user interface may permit subsets of raw data that are generated by sequential or iterative modifications and the settings used to generate the desired subset of data to be saved and identified at each iteration and in their totality.


In the preferred embodiment, the user interface utilizes one or more graphical, menu-driven formats (120) that can accept and display data sets, such as those from a flow cytometer with broad dynamic range. In an alternative embodiment, the user interface utilizes a numerical display format (122). The user interface permits the application of scaling and/or culling factors to the original data set to modify its display representation. In a first variation, the user interface simultaneously presents modified and raw representations of a single data set. In a second variation, the user interface simultaneously presents multiple data sets that can be simultaneously viewed, compared, and analyzed. The user can undo or otherwise alter the modifications (124) of one or more data sets using the menu-driven options.


The user interface of the preferred embodiment represents raw data and modified data using any suitable format, including graphically and numerically. The user interface enables observation of the consequences of scaling and/or culling modifications on a unique data set by simultaneous representation of raw and modified data. In one variation, separate graphs are generated from the raw and modified data and are displayed in separate frames, which preferably represents a preview of the export/print version of the viewed data. In an alternative variation, the raw and modified data are superimposed on one another in the same graph frame, with each data set preferably distinguished by color and/or shading. In yet another variation, the consequences of each modification applied to the raw data in the generation of the modified data are represented in independent planes of the same graph frame, and all modifications can be superimposed.


The fourth step of ‘reviewing and saving the modified settings’ (108) permits the user to identify the modifications made to the original data set (126) and to store the setting(s) used to generate the desired subset of data, thus allowing the user to save both the data and the corresponding scaling and/or culling parameters. The user interface provides virtual instrument settings (128) that can be adjusted, which generate a corresponding subset of data from the raw (i.e. original) data set. The user can repeat the steps of modifying the raw data and saving the desired subset of data and modified settings as many times as necessary and/or desirable, without the need for running additional sample through the flow cytometer. If the user generates the subset of data by making one or more alterations in the virtual settings, the user can access the previously saved alterations made to the subset of data and retrace or “undo” the alterations sequentially. In the preferred embodiment, the user interface will prompt the user to save the modified subset of data (l09), the settings used to generate the data (130), and any other pertinent information regarding the sample or data acquisition; in an alternative embodiment, the data settings are saved automatically. The user interface can apply hierarchical scaling factors (132) to independent data channels (e.g. scatter channels and fluorescent channels).


The fifth step of ‘exporting the saved data’ (110) permits the user to transfer the original (raw) data set and/or the modified subset of data from the flow cytometer system to a different medium, such as a printout or an electronic file. The data may be transferred to any suitable medium for subsequent viewing, analysis, and/or storage, and the settings used to generate the data and other pertinent information regarding the sample or data acquisition may also be included.


As a person skilled in the art of flow cytometry will recognize from the previous detailed description and from the figures and claims, modifications and changes can be made to the preferred embodiment of the invention without departing from the scope of this invention defined in the following claims.

Claims
  • 1. A method of extracting and manipulating data from a flow cytometer system comprising: collecting a full dynamic range of input signals from a flow cytometer sample into an initial data set that includes at least a 1:100,000 ratio between the faintest objects and the brightest objects;storing the initial data set of the full dynamic range of the input signals from the flow cytometer sample;allowing modification of the initial data set to manipulate the initial data set across the range of input signals from the flow cytometer sample; andstoring the modified data set.
  • 2. The method of claim 1, wherein collecting the full dynamic range of input signals includes collecting the full dynamic range of input signals to an initial data set that includes at least a 1:1,000,000 ratio between the faintest objects and the brightest objects.
  • 3. The method of claim 1, further comprising displaying the initial data set on a user interface.
  • 4. The method of claim 3, wherein displaying the initial data set includes permitting a user to observe the initial data set from the full dynamic range of input signals and permitting the user to identify the appropriate modifications for the initial data set.
  • 5. The method of claim 3, wherein displaying the initial data set includes acquiring the initial data set from the flow cytometer system coupled to the user interface and displaying the acquired initial data set on the user interface.
  • 6. The method of claim 1, further comprising exporting at least one of the stored initial data set and the stored modified data set to a different medium than the flow cytometer system.
  • 7. The method of claim 6, wherein exporting at least one of the stored initial data set and the stored modified data set includes permitting a user to transfer the modified data set from the flow cytometer system to a different medium.
  • 8. The method of claim 1, wherein allowing modification of the initial data set includes permitting a user to identify the modifications made to the initial data set.
  • 9. The method of claim 1, wherein collecting the full dynamic range of input signals includes collecting the full dynamic range of input signals to an initial data set with an error rate induced by electric noise of less than one percent.
  • 10. The method of claim 1, wherein collecting the full dynamic range of input signals includes collecting the input signals without accepting a gain amplification level selection from a user.
  • 11. The method of claim 1, wherein storing an initial data set includes storing to an electronic storage unit.
  • 12. The method of claim 1, wherein allowing modification of the initial data set includes permitting a user to manipulate the initial data set across the full dynamic range of input signals from the flow cytometer sample and to generate the modified data set.
  • 13. The method of claim 12, wherein allowing modification of the initial data set further includes permitting the user to perform real-time comparisons between the initial data set and the modified data set on a single flow cytometer sample.
  • 14. The method of claim 12, wherein allowing modification of the initial data set further includes permitting the user to adjust the bounds of the data in the initial data set.
  • 15. The method of claim 12, wherein allowing modification of the initial data set further includes permitting the user to adjust or undo modifications, to make multiple adjustments on the same initial data set.
  • 16. The method of claim 12, wherein allowing modification of the initial data set further includes permitting the user to generate at least one subset of data that corresponds to one or more sample populations contained within the initial data set.
  • 17. The method of claim 1, wherein allowing modification of the initial data set further includes permitting a user to store settings used to generate a desired subset of data.
  • 18. The method of claim 17, wherein allowing modification of the initial data set further includes providing adjustable virtual instrument settings.
  • 19. The method of claim 17, wherein allowing modifications of the initial data set further includes applying hierarchical scaling factors to independent data channels.
  • 20. The method of claim 17, wherein storing the modified data set further includes permitting the user to sequentially access previously stored modifications made to the subset of data in the settings.
  • 21. The method of claim 17, wherein storing the modified data set further includes at least one of storing modification parameters corresponding to the modified data set and storing other pertinent information regarding the sample or data acquisition.
  • 22. The method of claim 1, wherein allowing modification of the initial data set further includes utilizing a graphical, menu-driven format adapted to accept and display data sets.
  • 23. The method of claim 22, wherein utilizing a graphical, menu-driven format includes displaying, in separate graph frames, separate graphs that are generated from the initial data set and the modified data set.
  • 24. The method of claim 22, wherein utilizing a graphical, menu-driven format includes superimposing the initial data set and the modified data set on one another and displaying and distinguishing the data sets in the same graph frame.
  • 25. The method of claim 22, wherein utilizing a graphical, menu-driven format includes displaying, in independent planes of the same graph frame, the consequences of each modification applied to the initial data set in the generation of the modified data set.
  • 26. The method of claim 1, wherein allowing modification of the initial data set further includes utilizing a numerical display format.
  • 27. A method of extracting and manipulating data from a flow cytometer system comprising: collecting a full dynamic range of input signals from a flow cytometer sample into an initial data set;storing the initial data set of the full dynamic range of the input signals from the flow cytometer sample;allowing modification of the initial data set to manipulate the initial data set across the range of input signals from the flow cytometer sample, including permitting a user to identify the modifications made to the initial data set and permitting a user to store settings used to generate a desired subset of data from the initial data set; andstoring the modified data set.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of prior application Ser. No. 11/466,391 filed 22 Aug. 2006, now U.S. Pat. No. 7,996,188, which claims the benefit of U.S. Provisional Patent Application No. 60/710,102 filed on 22 Aug. 2005. Both applications are incorporated in their entirety by this reference.

US Referenced Citations (178)
Number Name Date Kind
3672402 Bloemer Jun 1972 A
4112735 McKnight Sep 1978 A
4138879 Liebermann Feb 1979 A
4371786 Kramer Feb 1983 A
4448538 Mantel May 1984 A
4559454 Kramer Dec 1985 A
4691829 Aue Sep 1987 A
4755021 Dyott Jul 1988 A
4790653 North, Jr. Dec 1988 A
4818103 Thomas et al. Apr 1989 A
4844610 North, Jr. Jul 1989 A
4933813 Berger Jun 1990 A
5028127 Spitzberg Jul 1991 A
5040890 North, Jr. Aug 1991 A
5043706 Oliver Aug 1991 A
5083862 Rusnak Jan 1992 A
5139609 Fields et al. Aug 1992 A
5150313 van den Engh et al. Sep 1992 A
5155543 Hirako Oct 1992 A
5204884 Leary et al. Apr 1993 A
5224058 Mickaels et al. Jun 1993 A
5230026 Ohta et al. Jul 1993 A
5270548 Steinkamp Dec 1993 A
5301685 Guirguis Apr 1994 A
5308990 Takahashi et al. May 1994 A
5367474 Auer et al. Nov 1994 A
5395588 North, Jr. et al. Mar 1995 A
5403552 Pardikes Apr 1995 A
5469375 Kosaka Nov 1995 A
5539386 Elliott Jul 1996 A
5552885 Steen Sep 1996 A
5684480 Jansson Nov 1997 A
5739902 Gjelsnes et al. Apr 1998 A
5798222 Goix Aug 1998 A
5883378 Irish et al. Mar 1999 A
5920388 Sandberg et al. Jul 1999 A
5981180 Chandler et al. Nov 1999 A
6016376 Ghaemi et al. Jan 2000 A
6039078 Tamari Mar 2000 A
6091502 Weigl et al. Jul 2000 A
6097485 Lievan Aug 2000 A
6108463 Herron et al. Aug 2000 A
6110427 Uffenheimer Aug 2000 A
6115065 Yadid-Pecht et al. Sep 2000 A
6139800 Chandler Oct 2000 A
6154276 Mariella, Jr. Nov 2000 A
6156208 Desjardins et al. Dec 2000 A
6181319 Fujita et al. Jan 2001 B1
6183697 Tanaka et al. Feb 2001 B1
6288783 Auad Sep 2001 B1
6377721 Walt et al. Apr 2002 B1
6382228 Cabuz et al. May 2002 B1
6403378 Phi-Wilson et al. Jun 2002 B1
6427521 Jakkula et al. Aug 2002 B2
6469787 Meyer et al. Oct 2002 B1
6473171 Buttry et al. Oct 2002 B1
6519355 Nelson Feb 2003 B2
6522775 Nelson Feb 2003 B2
6568271 Shah et al. May 2003 B2
6602469 Maus et al. Aug 2003 B1
6636623 Nelson et al. Oct 2003 B2
6675835 Gerner et al. Jan 2004 B2
6694799 Small Feb 2004 B2
6700130 Fritz Mar 2004 B2
6710871 Goix Mar 2004 B1
6778910 Vidal et al. Aug 2004 B1
6809804 Yount et al. Oct 2004 B1
6816257 Goix Nov 2004 B2
6825926 Turner et al. Nov 2004 B2
6852284 Holl et al. Feb 2005 B1
6859570 Walt et al. Feb 2005 B2
6869569 Kramer Mar 2005 B2
6872180 Reinhardt et al. Mar 2005 B2
6890487 Sklar et al. May 2005 B1
6897954 Bishop et al. May 2005 B2
6908226 Siddiqui et al. Jun 2005 B2
6912904 Storm, Jr. et al. Jul 2005 B2
6936828 Saccomanno Aug 2005 B2
6941005 Lary et al. Sep 2005 B2
6944322 Johnson et al. Sep 2005 B2
7009189 Saccomanno Mar 2006 B2
7012689 Sharpe Mar 2006 B2
7019834 Sebok et al. Mar 2006 B2
7024316 Ellison et al. Apr 2006 B1
7061595 Cabuz et al. Jun 2006 B2
7075647 Christodoulou Jul 2006 B2
7105355 Kurabayashi et al. Sep 2006 B2
7106442 Silcott et al. Sep 2006 B2
7113266 Wells Sep 2006 B1
7130046 Fritz et al. Oct 2006 B2
7232687 Lary et al. Jun 2007 B2
7262838 Fritz Aug 2007 B2
7274316 Moore Sep 2007 B2
7362432 Roth Apr 2008 B2
7471393 Trainer Dec 2008 B2
7486387 Fritz Feb 2009 B2
7738099 Morrell et al. Jun 2010 B2
7739060 Goebel et al. Jun 2010 B2
7843561 Rich Nov 2010 B2
7996188 Olson et al. Aug 2011 B2
8004674 Ball et al. Aug 2011 B2
8077310 Olson et al. Dec 2011 B2
20010014477 Pelc et al. Aug 2001 A1
20020028434 Goix et al. Mar 2002 A1
20020049782 Herzenberg Apr 2002 A1
20020059959 Qatu et al. May 2002 A1
20020080341 Kosaka Jun 2002 A1
20020097392 Minneman et al. Jul 2002 A1
20020123154 Burshteyn et al. Sep 2002 A1
20020192113 Uffenheimer et al. Dec 2002 A1
20030035168 Qian et al. Feb 2003 A1
20030048539 Oostman et al. Mar 2003 A1
20030054558 Kurabayashi Mar 2003 A1
20030062314 Davidson et al. Apr 2003 A1
20030072549 Facer et al. Apr 2003 A1
20030078703 Potts et al. Apr 2003 A1
20030129090 Farrell Jul 2003 A1
20030134330 Ravkin et al. Jul 2003 A1
20030148379 Roitman et al. Aug 2003 A1
20030151741 Wolleschensky et al. Aug 2003 A1
20030175157 Micklash et al. Sep 2003 A1
20030202175 van den Engh et al. Oct 2003 A1
20030211009 Buchanan Nov 2003 A1
20030223061 Sebok Dec 2003 A1
20030235919 Chandler Dec 2003 A1
20040031521 Vrane et al. Feb 2004 A1
20040048362 Trulson et al. Mar 2004 A1
20040112808 Takagi et al. Jun 2004 A1
20040119974 Bishop et al. Jun 2004 A1
20040123645 Storm et al. Jul 2004 A1
20040131322 Ye et al. Jul 2004 A1
20040143423 Parks et al. Jul 2004 A1
20040175837 Bonne et al. Sep 2004 A1
20040201845 Quist et al. Oct 2004 A1
20040246476 Bevis et al. Dec 2004 A1
20050044110 Herzenberg Feb 2005 A1
20050047292 Park et al. Mar 2005 A1
20050057749 Dietz et al. Mar 2005 A1
20050069454 Bell Mar 2005 A1
20050073686 Roth et al. Apr 2005 A1
20050078299 Fritz et al. Apr 2005 A1
20050105091 Lieberman et al. May 2005 A1
20050162648 Auer et al. Jul 2005 A1
20050163663 Martino et al. Jul 2005 A1
20050195605 Saccomanno et al. Sep 2005 A1
20050195684 Mayer Sep 2005 A1
20050252574 Khan et al. Nov 2005 A1
20060002634 Riley et al. Jan 2006 A1
20060015291 Parks et al. Jan 2006 A1
20060023219 Meyer et al. Feb 2006 A1
20060161057 Weber Jul 2006 A1
20060219873 Martin et al. Oct 2006 A1
20060240411 Mehrpouyan et al. Oct 2006 A1
20060281143 Liu et al. Dec 2006 A1
20060286549 Sohn et al. Dec 2006 A1
20070003434 Padmanabhan et al. Jan 2007 A1
20070041013 Fritz et al. Feb 2007 A1
20070096039 Kapoor et al. May 2007 A1
20070124089 Jochum et al. May 2007 A1
20070134089 Lee et al. Jun 2007 A1
20070188737 Fritz Aug 2007 A1
20070212262 Rich Sep 2007 A1
20070224684 Olson et al. Sep 2007 A1
20080055595 Olson et al. Mar 2008 A1
20080152542 Ball et al. Jun 2008 A1
20080215297 Goebel et al. Sep 2008 A1
20080228444 Olson et al. Sep 2008 A1
20080263468 Cappione Amedeo et al. Oct 2008 A1
20090104075 Rich Apr 2009 A1
20090202130 George et al. Aug 2009 A1
20090216478 Estevez Aug 2009 A1
20100012853 Parks Jan 2010 A1
20100032584 Dayong et al. Feb 2010 A1
20100118298 Bair et al. May 2010 A1
20100271620 Goebel et al. Oct 2010 A1
20100302536 Ball et al. Dec 2010 A1
20110008816 Ball et al. Jan 2011 A1
20110204259 Rogers et al. Aug 2011 A1
Foreign Referenced Citations (16)
Number Date Country
1396736 Mar 2004 EP
356169978 Dec 1981 JP
04086546 Mar 1992 JP
10227737 Aug 1998 JP
2005017499 Feb 2005 WO
2005068971 Jul 2005 WO
2005073694 Aug 2005 WO
2005091893 Oct 2005 WO
2006055722 May 2006 WO
2007103969 Sep 2007 WO
2007100723 Sep 2007 WO
2008058217 May 2008 WO
2010101623 Sep 2010 WO
2011106402 Sep 2011 WO
2011159708 Dec 2011 WO
2012030740 Mar 2012 WO
Related Publications (1)
Number Date Country
20120004859 A1 Jan 2012 US
Provisional Applications (1)
Number Date Country
60710102 Aug 2005 US
Continuations (1)
Number Date Country
Parent 11466391 Aug 2006 US
Child 13175926 US